Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.59B |
| 2 |
TotalEnergies
TTE
|
+$1.27B |
| 3 |
Warner Bros
WBD
|
+$838M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$782M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$707M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$2.77B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.27B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.6B |
| 5 |
Microsoft
MSFT
|
+$1.58B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.21% |
| 2 | Financials | 9.57% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Healthcare | 7.31% |
| 5 | Communication Services | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETB
6026
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$458M
| $154K | ﹤0.01% |
+10,060
| New | +$152K |
|
|
STEX
6027
Streamex Corp
STEX
$75.6M
| $152K | ﹤0.01% |
+50,248
| New | +$225K |
|
6028
Ampco-Pittsburgh
AP
$192M
| $151K | ﹤0.01% |
28,251
-3,597
| -11% | -$9.95K |
|
6029
Vince Holding Corp
VNCE
$83.9M
| $151K | ﹤0.01% |
+36,898
| New | +$113K |
|
|
ONCY
6030
Oncolytics Biotech
ONCY
$95.1M
| $148K | ﹤0.01% |
169,899
-38,799
| -19% | -$41.9K |
|
6031
Upland Software
UPLD
$12.8M
| $148K | ﹤0.01% |
10,383
+1,359
| +15% | +$25.9K |
|
6032
Journey Medical
DERM
$176M
| $148K | ﹤0.01% |
19,203
-14,850
| -44% | -$116K |
|
6033
IZEA Worldwide
IZEA
$61.6M
| $148K | ﹤0.01% |
33,768
-10,023
| -23% | -$48.7K |
|
|
PROF
6034
Profound Medical
PROF
$290M
| $147K | ﹤0.01% |
18,727
+6,787
| +57% | +$43.6K |
|
6035
Lifezone Metals
LZM
$355M
| $147K | ﹤0.01% |
34,499
-50,806
| -60% | -$230K |
|
6036
SEALSQ Corp
LAES
$548M
| $147K | ﹤0.01% |
+38,905
| New | +$198K |
|
6037
Critical Metals Corp Warrants
CRMLW
$17.4M
| $147K | ﹤0.01% |
53,823
| – | – |
|
6038
Jerash Holdings
JRSH
$61M
| $147K | ﹤0.01% |
48,083
+30,055
| +167% | +$95.6K |
|
6039
BlackRock Credit Allocation Income Trust
BTZ
$935M
| $143K | ﹤0.01% |
+13,205
| New | +$145K |
|
|
TVRD
6040
Tvardi Therapeutics
TVRD
$18.8M
| $142K | ﹤0.01% |
33,131
+9,102
| +38% | +$81.6K |
|
|
NXXT
6041
NextNRG Inc
NXXT
$47M
| $141K | ﹤0.01% |
97,264
+64,472
| +197% | +$111K |
|
6042
Bioceres Crop Solutions
BIOX
$23.2M
| $141K | ﹤0.01% |
107,641
+81,924
| +319% | +$131K |
|
6043
Siebert Financial
SIEB
$65.9M
| $141K | ﹤0.01% |
40,133
-34,064
| -46% | -$108K |
|
6044
Noble Corporation PLC Tranche 2 Warrants
NE.WS.A
$2.51B
| $141K | ﹤0.01% |
16,891
| – | – |
|
6045
CALL
Bakkt Inc
BKKT
$330M
| $141K | ﹤0.01% |
+14,000
| New | +$309K |
|
|
CMCM
6046
Cheetah Mobile
CMCM
$92.5M
| $139K | ﹤0.01% |
23,131
+3,443
| +17% | +$24.8K |
|
6047
Imperial Petroleum
IMPP
$209M
| $138K | ﹤0.01% |
38,126
-115,265
| -75% | -$567K |
|
6048
Zedge
ZDGE
$38.8M
| $138K | ﹤0.01% |
42,029
+11,022
| +36% | +$31.9K |
|
|
INV
6049
Innventure Inc
INV
$287M
| $138K | ﹤0.01% |
32,924
+4,638
| +16% | +$19.5K |
|
|
FIRY
6050
Firy Inc
FIRY
$154M
| $137K | ﹤0.01% |
31,875
-6,391
| -17% | -$39.5K |
|
Similar funds
Goldman Sachs's Q4 2025 Portfolio in Review
As of Q4 2025, Goldman Sachs held 6,954 positions worth $815B, down 0.25% from $817B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q4 2025 filing shows 640 new, 3,023 increased, 2,153 reduced and 543 closed positions. Its largest new stake was SunocoCorp LLC: 2,575,806 shares worth $127M. The largest sale was TC Energy, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q4 2025 buy was SunocoCorp LLC: 2,575,806 shares worth $127M.
- Goldman Sachs added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2025, an estimated $1.59B increase.
- Goldman Sachs's biggest Q4 2025 reduction was TC Energy, cutting an estimated $2.77B.
- Goldman Sachs fully exited Verona Pharma in Q4 2025, selling an estimated $207M.
- Goldman Sachs's ten largest holdings make up 22% of its $815B portfolio in Q4 2025.
- Goldman Sachs opened 640 new positions and closed 543 in Q4 2025.
- Goldman Sachs's portfolio value fell 0.25% quarter-over-quarter to $815B.
Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.